Holding(s) in Company

Summary by AI BETAClose X

UBS AG has notified Renalytix PLC of a change in its major shareholding, reporting a decrease in voting rights from 7.631241% to 6.999480% as of March 17, 2026. This change, representing 30,589,034 voting rights, is due to an acquisition or disposal of voting rights. The notification was made by UBS Group AG's Investment Bank & Global Wealth Management, with UBS AG being the entity holding the shares.

Disclaimer*

UK 100

Latest directors dealings